MG
Clinical trials for MG explained in plain language.
Never miss a new study
Get alerted when new MG trials appear
Sign up with your email to follow new studies for MG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for MG patients: study tests safer drug combos
Disease control Recruiting nowThis study is testing different drug combinations to find safer and more effective treatments for people with myasthenia gravis, a condition that causes muscle weakness. About 70 adults with generalized MG will try either a new drug alone or added to their current treatment. The …
Matched conditions: MG
Sponsor: argenx • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Engineered immune cells take aim at lupus and MS
Disease control Recruiting nowThis early-stage study tests a new treatment called RD06-05, which uses a patient's own immune cells modified to target and calm overactive immune cells in autoimmune diseases. The trial includes 18 adults with conditions like lupus, systemic sclerosis, multiple sclerosis, and ot…
Matched conditions: MG
Phase: EARLY_PHASE1 • Sponsor: Nanjing Bioheng Biotech Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New drug combo aims to ease severe muscle weakness
Disease control Recruiting nowThis study tests whether adding empasiprubart to the standard treatment efgartigimod can further improve symptoms in people with a specific type of generalized myasthenia gravis (gMG). About 70 adults who still have partial symptoms despite efgartigimod will receive the combinati…
Matched conditions: MG
Phase: PHASE2 • Sponsor: argenx • Aim: Disease control
Last updated May 07, 2026 18:41 UTC